Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma
NPC patients with smoking history, thyroid nodules, and cervical lymph node metastasis have significantly increased risk of thyroid dysfunction when receiving anti-PD-1 immunotherapy combined with IMRT. The combination of anti-PD-1 immunotherapy and IMRT increases both the incidence and severity of thyroid dysfunction.
Authors
- Shanyi Chen
- Xianming Li (ORCID: https://orcid.org/0000-0001-8364-0991)
- Shihai Wu (ORCID: https://orcid.org/0000-0002-5833-9723)
- Yucong Zhang (ORCID: https://orcid.org/0000-0002-2991-5066)
- Gang Xu (ORCID: https://orcid.org/0000-0003-2094-8125)
- Zihuang Li
- Long Gong
- Liqianqi Chen
Institutions
- Jinan University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.3389/fimmu.2024.1495946
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Shenzhen Science and Technology Innovation Program